Acquisitive Pfizer to strike again? Seagen back in M&A talks after Merck walked away: WSJ
A potential buyout of Seagen by Pfizer would be likely to clear antitrust concerns because of “limited overlap,” between the companies, said analysts at Berenberg Capital Markets.